135 related articles for article (PubMed ID: 15030283)
21. The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor.
Tsikaris V
J Pept Sci; 2004 Oct; 10(10):589-602. PubMed ID: 15526708
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein IIb/IIIa inhibitors in the elderly: fear of age or age of fear?
Montalescot G
Circulation; 2006 Nov; 114(19):2004-6. PubMed ID: 17088473
[No Abstract] [Full Text] [Related]
23. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
Cohen M
Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
[TBL] [Abstract][Full Text] [Related]
24. GPIIb/IIIa inhibitor-induced dethrombosis.
Furman MI; Frelinger AL; Michelson AD
J Thromb Thrombolysis; 2004 Aug; 18(1):11-7. PubMed ID: 15744548
[TBL] [Abstract][Full Text] [Related]
25. Current strategies with high-dose tirofiban.
Mukherjee D; Roffi M
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):275-80. PubMed ID: 17428156
[TBL] [Abstract][Full Text] [Related]
26. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
27. Clinical importance of antiplatelet drugs in cardiovascular diseases.
Papp J; Kenyeres P; Toth K
Clin Hemorheol Microcirc; 2013; 53(1-2):81-96. PubMed ID: 22954637
[TBL] [Abstract][Full Text] [Related]
28. [Reflections on GPIIb/IIIA inhibitors ... and all around ...].
Neri Serneri GG
G Ital Cardiol; 1999 Apr; 29(4):467-71. PubMed ID: 10327329
[No Abstract] [Full Text] [Related]
29. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Mousa SA
Curr Pharm Des; 2003; 9(28):2317-22. PubMed ID: 14529393
[TBL] [Abstract][Full Text] [Related]
30. [Platelet aggregation disorders].
Patscheke H
Hamostaseologie; 2003 Nov; 23(4):181-5. PubMed ID: 14603382
[TBL] [Abstract][Full Text] [Related]
31. Specific glycoprotein IIb/IIIa antagonists and inflammation.
Ercan E
Int J Cardiol; 2004 Mar; 94(1):121-2. PubMed ID: 14996486
[No Abstract] [Full Text] [Related]
32. Cardiology. Attention shifts to the white clot.
Narins CR; Topol EJ
Lancet; 1997 Dec 20-27; 350 Suppl 3():SIII2. PubMed ID: 9465178
[No Abstract] [Full Text] [Related]
33. Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries?
Shlansky-Goldberg R
J Vasc Interv Radiol; 2002 Mar; 13(3):229-46. PubMed ID: 11875083
[TBL] [Abstract][Full Text] [Related]
34. Use of concomitant glycoprotein IIb/IIIa inhibitors with catheter-directed peripheral arterial thrombolysis.
Ouriel K
J Vasc Interv Radiol; 2004 Jun; 15(6):543-6. PubMed ID: 15178713
[No Abstract] [Full Text] [Related]
35. Role of antiplatelet agents in stroke.
Mousa SA
Curr Opin Investig Drugs; 2000 Dec; 1(4):464-7. PubMed ID: 11249700
[No Abstract] [Full Text] [Related]
36. Novel antiplatelet drugs in clinical development.
Ungerer M; Münch G
Thromb Haemost; 2013 Nov; 110(5):868-75. PubMed ID: 24108565
[TBL] [Abstract][Full Text] [Related]
37. [Platelet antiaggregants in the treatment of vasculopathies].
Honorato J; Montes-Jovellar B
Angiologia; 1990; 42(1):1-10. PubMed ID: 2181892
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical thrombosis prevention in cardiovascular disease.
Eriksson M; Christensen K; Lindahl TL; Larsson A
Expert Opin Investig Drugs; 2002 Apr; 11(4):553-63. PubMed ID: 11922863
[TBL] [Abstract][Full Text] [Related]
39. [The history of the SET-UP study (or how difficult is neutrality in clinical research)].
Tavazzi L; Maggioni AP
Ital Heart J Suppl; 2000 Apr; 1(4):582-3. PubMed ID: 10832152
[No Abstract] [Full Text] [Related]
40. Aspirin, "super aspirin" use in women for cardioprevention probed.
Mitka M
JAMA; 2006 Jan; 295(1):20-1. PubMed ID: 16391206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
